Raynaud's disease
Get the facts on Raynaud’s and symptoms
Find out more
We are here for you.
Whether you are newly diagnosed or have been living with Scleroderma and Raynaud's for years, we can help. SRUK are the only UK charity providing support and information and funding research into Scleroderma and Raynaud's.
SRUK is dedicated to improving the lives of people with scleroderma and Raynaud's phenomenon
Our mission is to improve the lives of everyone affected by scleroderma and Raynaud's. We do this by investing in research, improving awareness and understanding of the conditions and providing information and support to all those affected.
Fundraise for SRUK
Whether you want to run a marathon, bake cakes or host an online quiz, we are here with tips and support to help you raise vital funds for us. Take a look at our A-Z of home fundraising ideas for some inspiration to get you started.
Make a Donation to SRUK
Help support the life-changing work of Scleroderma and Raynaud's UK and support people with the conditions
SRUK latest news
See all newsWednesday 21st October 2020
Warp speed to a COVID-19 vaccine? The race is on!
In the fight against coronavirus, an effective vaccination could be the game-changer that the world is waiting for. It typically takes several years to develop a new vaccine, so how close are we to finding a real vaccination for coronavirus, and how might this work to protect us?
Friday 9th October 2020
Have you given your risk of flu a second thought?
Many people are entitled to a free flu jab this year, and you may have received a letter about this. But why is this important and what are the benefits? And is there anyone who should not have the flu vaccine? We have all the answers you need.
Friday 2nd October 2020
Joint statement on rise in COVID-19 cases in the UK
Together with our partner organisations of RAIRDA (The Rare Autoimmune Rheumatic Diseases Alliance), we have released a joint statement in response to the recent rise in coronavirus cases. This is regarding the effect of the pandemic on the ongoing, continuing care of people with rare, autoimmune conditions, including scleroderma; as well as the issue of shielding.
Give us your website feedback
Help us make our website best suit the needs of our community